HEVG - Overview: Hepatitis E Virus IgG Antibody, Serum
Diagnosis of past exposure to hepatitis E virus
HMB45 - Overview: HMB45 Immunostain, Technical Component Only
Identification of activated and neoplastic melanocytes
GAB1 - Overview: GRB2-Associated Binding Protein 1 (GAB1) Immunostain, Technical Component Only
Identification and differentiation of medulloblastomas
GRH - Overview: Growth Hormone Immunostain, Technical Component Only
Aids in the identification of growth hormone adenomas
GLYP3 - Overview: Glypican-3 Immunostain, Technical Component Only
Differentiating hepatocellular carcinomas from other malignancies and hepatic adenomas
HCQ - Overview: Hydroxychloroquine, Serum
Monitoring serum hydroxychloroquine concentrations, assessing compliance, and adjusting dosage in patients
GALN3 - Overview: Galectin-3 Immunostain, Technical Component Only
Distinguishing normal and benign thyroid gland from thyroid carcinoma
FACR8 - Overview: Factor 8 Related Antigen Immunostain, Technical Component Only
Marker of endothelial cell lineage
FLI1 - Overview: FLI-1 Immunostain, Technical Component Only
Aiding in phenotyping endothelial-derived tumors, Ewing sarcoma, Merkel cell carcinoma, lung adenocarcinoma, melanoma, and erythroleukemia
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...